EP1745814A3 — Needle-free injection system
Assigned to Bioject Inc · Expires 2007-03-14 · 19y expired
What this patent protects
A needle-free injection device (22) is described. The injection device includes a user-grippable housing (26) and a syringe assembly (28) movably secured to the housing. The syringe assembly is configured to expel injectable fluid out of a nozzle (30) upon application of pressuri…
USPTO Abstract
A needle-free injection device (22) is described. The injection device includes a user-grippable housing (26) and a syringe assembly (28) movably secured to the housing. The syringe assembly is configured to expel injectable fluid out of a nozzle (30) upon application of pressurized gas to the syringe assembly. The injection device also includes a pressurized gas delivery mechanism disposed within the housing and configured to selectively apply pressurized gas to the syringe assembly. The pressurized gas delivery mechanism is at least partly actuated by pressing the nozzle onto an injection site so that the syringe assembly moves relative to the housing.
Drugs covered by this patent
- Lignospan Forte (Lidocaine Hydrochloride) · Fresenius Kabi
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.